US Patent Issued to Karuna Therapeutics on Feb. 24 for "Compositions and methods for treating disorders ameliorated by muscarinic receptor activation" (Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,317, issued on Feb. 24, was assigned to Karuna Therapeutics Inc. (Princeton, N.J.).

"Compositions and methods for treating disorders ameliorated by muscarinic receptor activation" was invented by Aimesther Betancourt (Montreal), Bruce Rehlaender (Lake Oswego, Ore.) and Roch Thibert (Mont-Royal, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium."

The patent was filed on Dec. 21, 2023, under Application No. 18/392,891....